Home

About Us

Answers to frequently asked questions about tuberculosis are provided along with a brief overview of tuberculosis. The overview includes history, epidemiology, transmission and pathogenesis, diagnosis, treatment and infection control.

Northeastern RTMCC

Education & Training

Products & Resources

Links & Search

Contact Us

LTBI Drug Card References

CDC. (2011) Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. (MMWR 2011; 60:1650–1653). Atlanta, GA http://www.cdc.gov/mmwr/pdf/wk/mm6048.pdf

CDC. (2010). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. (MMWR 2010; 59 (RR-5); 1-25). Atlanta, GA http://www.cdc.gov/mmwr/pdf/rr/rr5905.pdf

CDC. (2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the national tuberculosis controllers association and CDC. (MMWR 2005; 54 [No. RR-15, 1-37]). Atlanta, GA http://www.cdc.gov/mmwr/pdf/rr/rr5415.pdf

CDC. (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. (MMWR 2000; 49 [No. RR-6]). Atlanta, GA http://www.cdc.gov/mmwr/pdf/rr/rr4906.pdf

CDC. (2011) Treatment of latent tuberculosis infection: Maximizing adherence. (Fact Sheet) Atlanta, GA http://www.cdc.gov/tb/publications/factsheets/treatment/ltbiadherence.pdf

CDC. (2012) Treatment options for latent tuberculosis infection. (Fact Sheet) Atlanta, GA http://www.cdc.gov/publications/factsheets/treatment/LTBItreatmentoptions.pdf

CDC. What you need to know about your medicine for latent tuberculosis (TB) infection: Isoniazid-specific regimen (Fact Sheet Series) Atlanta, GA http://www.cdc.gov/tb/publications/PDF/INH_508.pdf

CDC. What you need to know about your medicine for latent tuberculosis (TB) infection: Rifampin-specific regimen (Fact Sheet Series) Atlanta, GA http://www.cdc.gov/tb/publications/PDF/RIF_508.pdf

CDC. What you need to know about your medicine for latent tuberculosis (TB) infection: Isoniazid and Rifapentine-specific regimen (Fact Sheet Series) Atlanta, GA http://www.cdc.gov/tb/publications/PDF/3HP_508.pdf

CDC. (2010) Latent tuberculosis infection: A guide for primary health care providers (CDC and NJMS GTBI). Atlanta, GA http://www.cdc.gov/tb/publications/lLTBI/pdf/TargetedLTBI.pdf

CDC. (2011) Recommendations for use of an isoniazid–rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection (Addendum) Atlanta, GA http://www.cdc.gov/tb/publications/LTBI/pdf/LTNI_CC_addendum.pdf

CDC. (2011) Core curriculum on tuberculosis: What the clinician should know (Guides and Toolkits) Atlanta, GA http://www.cdc.gov/tb/education/corecurr/_all_pdf

American Academy of Pediatrics (2012) Red Book: Report of the Committee on Infectious Diseases of the American Academy of Pediatrics. Elk Grove Village, IL. http://aapredbook.aappublications.org/